BioSpace

GSK, Ionis win FDA nod for hepatitis B functional cure that controls virus after treatment

Hibsago’s approval—a functional cure for certain patients with a hepatitis B infection—further validates Ionis Pharmaceuticals’ antisense platform, which has already generated two other new drug approvals this year.

By BioSpace

1 min read
GSK, Ionis win FDA nod for hepatitis B functional cure that controls virus after treatment
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights